Tarsheen Sethi
Last active: 1/29/2018

Profile

My primary clinical and research interest involves clinical investigation aimed at improving care and outcome of Hodgkin and Non-Hodgkin lymphoma patients. I am also interested in the applications of tumor immunology and immunotherapy to hematologic malignancies focusing on lymphoma. My overall goal is to be a clinician scientist, initiating clinical trials that utilize novel agents and advancing correlative science including biomarker development. In addition, I want to understand and apply principles of risk stratification for treatment selection aimed at optimizing efficacy and minimizing toxicity.

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma. Sethi T, Nguyen V, Li S, Morgan D, Greer J, Reddy N (2017) Ther Adv Hematol 8(1): 13-20
    › Primary publication · 28042455 (PubMed) · PMC5167078 (PubMed Central)
  2. Beyond Epstein-Barr virus: genetic predisposition of natural killer T-cell lymphoma. Reddy NM, Sethi TK (2016) Lancet Oncol 17(9): 1176-7
    › Primary publication · 27470080 (PubMed)
  3. Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome. Aghighi M, Boe J, Rosenberg J, Von Eyben R, Gawande RS, Petit P, Sethi TK, Sharib J, Marina NM, DuBois SG, Daldrup-Link HE (2016) Radiology 280(3): 905-15
    › Primary publication · 26982677 (PubMed) · PMC5006736 (PubMed Central)
  4. Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas. Sethi TK, Keedy VL (2016) Curr Treat Options Oncol 17(2): 11
    › Primary publication · 26931561 (PubMed)
  5. Radon and lung cancer. Sethi TK, El-Ghamry MN, Kloecker GH (2012) Clin Adv Hematol Oncol 10(3): 157-64
    › Primary publication · 22402423 (PubMed)
  6. Iron deficiency masquerading as idiopathic intracranial hypertension. Kaul B, Ramanarayanan S, R S, Mahapatra H, Sethi TK, Ahlawat R (2009) BMJ Case Rep
    › Primary publication · 21686848 (PubMed) · PMC3028304 (PubMed Central)